nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcipotriol—psoriasis—skin cancer	0.861	1	CtDrD
Calcipotriol—Application site erythema—Imiquimod—skin cancer	0.00764	0.0988	CcSEcCtD
Calcipotriol—VDR—leg—skin cancer	0.00719	0.117	CbGeAlD
Calcipotriol—VDR—forelimb—skin cancer	0.00714	0.116	CbGeAlD
Calcipotriol—VDR—hindlimb—skin cancer	0.00642	0.104	CbGeAlD
Calcipotriol—Instillation site pain—Imiquimod—skin cancer	0.00552	0.0714	CcSEcCtD
Calcipotriol—VDR—appendage—skin cancer	0.00551	0.0894	CbGeAlD
Calcipotriol—Localized exfoliation—Bleomycin—skin cancer	0.00475	0.0614	CcSEcCtD
Calcipotriol—VDR—skin epidermis—skin cancer	0.00458	0.0744	CbGeAlD
Calcipotriol—Application site pain—Imiquimod—skin cancer	0.00409	0.0529	CcSEcCtD
Calcipotriol—Folliculitis—Vemurafenib—skin cancer	0.00336	0.0434	CcSEcCtD
Calcipotriol—VDR—hair follicle—skin cancer	0.00327	0.0531	CbGeAlD
Calcipotriol—Skin hyperpigmentation—Imiquimod—skin cancer	0.00303	0.0391	CcSEcCtD
Calcipotriol—Folliculitis—Imiquimod—skin cancer	0.00286	0.037	CcSEcCtD
Calcipotriol—MPO—endothelium—skin cancer	0.00281	0.0455	CbGeAlD
Calcipotriol—MPO—blood vessel—skin cancer	0.00259	0.042	CbGeAlD
Calcipotriol—Skin irritation—Fluorouracil—skin cancer	0.0023	0.0297	CcSEcCtD
Calcipotriol—Application site pain—Fluorouracil—skin cancer	0.00226	0.0292	CcSEcCtD
Calcipotriol—Tingling sensation—Imiquimod—skin cancer	0.00224	0.029	CcSEcCtD
Calcipotriol—Stinging—Imiquimod—skin cancer	0.00222	0.0287	CcSEcCtD
Calcipotriol—VDR—nipple—skin cancer	0.00222	0.036	CbGeAlD
Calcipotriol—VDR—neck—skin cancer	0.00219	0.0356	CbGeAlD
Calcipotriol—Skin hyperpigmentation—Bleomycin—skin cancer	0.00215	0.0278	CcSEcCtD
Calcipotriol—CYP24A1—female reproductive system—skin cancer	0.00201	0.0327	CbGeAlD
Calcipotriol—Folliculitis—Dactinomycin—skin cancer	0.0019	0.0245	CcSEcCtD
Calcipotriol—Skin exfoliation—Imiquimod—skin cancer	0.00172	0.0222	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Fluorouracil—skin cancer	0.00167	0.0216	CcSEcCtD
Calcipotriol—VDR—connective tissue—skin cancer	0.00157	0.0255	CbGeAlD
Calcipotriol—VDR—epithelium—skin cancer	0.00149	0.0242	CbGeAlD
Calcipotriol—VDR—skin of body—skin cancer	0.00142	0.023	CbGeAlD
Calcipotriol—Dry skin—Vemurafenib—skin cancer	0.0014	0.0182	CcSEcCtD
Calcipotriol—MPO—connective tissue—skin cancer	0.00133	0.0215	CbGeAlD
Calcipotriol—VDR—mammalian vulva—skin cancer	0.0013	0.021	CbGeAlD
Calcipotriol—MPO—epithelium—skin cancer	0.00126	0.0204	CbGeAlD
Calcipotriol—Tingling sensation—Fluorouracil—skin cancer	0.00124	0.016	CcSEcCtD
Calcipotriol—Stinging—Fluorouracil—skin cancer	0.00123	0.0159	CcSEcCtD
Calcipotriol—Skin exfoliation—Bleomycin—skin cancer	0.00122	0.0158	CcSEcCtD
Calcipotriol—Skin hyperpigmentation—Docetaxel—skin cancer	0.00121	0.0156	CcSEcCtD
Calcipotriol—MPO—skin of body—skin cancer	0.0012	0.0194	CbGeAlD
Calcipotriol—VDR—lymphoid tissue—skin cancer	0.00115	0.0187	CbGeAlD
Calcipotriol—VDR—female reproductive system—skin cancer	0.00111	0.018	CbGeAlD
Calcipotriol—Pain—Vismodegib—skin cancer	0.00104	0.0135	CcSEcCtD
Calcipotriol—Skin exfoliation—Temozolomide—skin cancer	0.00103	0.0133	CcSEcCtD
Calcipotriol—MPO—lymphoid tissue—skin cancer	0.00097	0.0157	CbGeAlD
Calcipotriol—VDR—head—skin cancer	0.000927	0.015	CbGeAlD
Calcipotriol—Erythema—Vemurafenib—skin cancer	0.000922	0.0119	CcSEcCtD
Calcipotriol—Pruritus—Vismodegib—skin cancer	0.000862	0.0111	CcSEcCtD
Calcipotriol—Erythema—Imiquimod—skin cancer	0.000787	0.0102	CcSEcCtD
Calcipotriol—MPO—head—skin cancer	0.000782	0.0127	CbGeAlD
Calcipotriol—Rash—Vismodegib—skin cancer	0.000768	0.00994	CcSEcCtD
Calcipotriol—Dermatitis—Vismodegib—skin cancer	0.000768	0.00993	CcSEcCtD
Calcipotriol—Dry skin—Temozolomide—skin cancer	0.000717	0.00928	CcSEcCtD
Calcipotriol—Skin exfoliation—Docetaxel—skin cancer	0.000685	0.00885	CcSEcCtD
Calcipotriol—Dry skin—Fluorouracil—skin cancer	0.000661	0.00855	CcSEcCtD
Calcipotriol—VDR—lymph node—skin cancer	0.000649	0.0105	CbGeAlD
Calcipotriol—Paraesthesia—Imiquimod—skin cancer	0.000576	0.00746	CcSEcCtD
Calcipotriol—Erythema—Bleomycin—skin cancer	0.000559	0.00723	CcSEcCtD
Calcipotriol—Hypersensitivity—Vemurafenib—skin cancer	0.000555	0.00717	CcSEcCtD
Calcipotriol—Pain—Imiquimod—skin cancer	0.000549	0.0071	CcSEcCtD
Calcipotriol—MPO—lymph node—skin cancer	0.000547	0.00888	CbGeAlD
Calcipotriol—Pruritus—Vemurafenib—skin cancer	0.000533	0.00689	CcSEcCtD
Calcipotriol—Erythema—Dactinomycin—skin cancer	0.000521	0.00674	CcSEcCtD
Calcipotriol—Dry skin—Docetaxel—skin cancer	0.000477	0.00617	CcSEcCtD
Calcipotriol—Rash—Vemurafenib—skin cancer	0.000475	0.00614	CcSEcCtD
Calcipotriol—Dermatitis—Vemurafenib—skin cancer	0.000474	0.00613	CcSEcCtD
Calcipotriol—Hypersensitivity—Imiquimod—skin cancer	0.000473	0.00612	CcSEcCtD
Calcipotriol—Erythema—Temozolomide—skin cancer	0.000471	0.0061	CcSEcCtD
Calcipotriol—Pruritus—Imiquimod—skin cancer	0.000454	0.00587	CcSEcCtD
Calcipotriol—Erythema—Fluorouracil—skin cancer	0.000434	0.00562	CcSEcCtD
Calcipotriol—Paraesthesia—Bleomycin—skin cancer	0.00041	0.0053	CcSEcCtD
Calcipotriol—Rash—Imiquimod—skin cancer	0.000405	0.00524	CcSEcCtD
Calcipotriol—Dermatitis—Imiquimod—skin cancer	0.000404	0.00523	CcSEcCtD
Calcipotriol—Pain—Bleomycin—skin cancer	0.00039	0.00504	CcSEcCtD
Calcipotriol—Pain—Dactinomycin—skin cancer	0.000364	0.0047	CcSEcCtD
Calcipotriol—Paraesthesia—Temozolomide—skin cancer	0.000345	0.00447	CcSEcCtD
Calcipotriol—Hypersensitivity—Bleomycin—skin cancer	0.000336	0.00435	CcSEcCtD
Calcipotriol—Pain—Temozolomide—skin cancer	0.000329	0.00426	CcSEcCtD
Calcipotriol—Pruritus—Bleomycin—skin cancer	0.000323	0.00417	CcSEcCtD
Calcipotriol—Paraesthesia—Fluorouracil—skin cancer	0.000318	0.00412	CcSEcCtD
Calcipotriol—Erythema—Docetaxel—skin cancer	0.000313	0.00405	CcSEcCtD
Calcipotriol—Hypersensitivity—Dactinomycin—skin cancer	0.000313	0.00405	CcSEcCtD
Calcipotriol—Pain—Fluorouracil—skin cancer	0.000303	0.00392	CcSEcCtD
Calcipotriol—Rash—Bleomycin—skin cancer	0.000288	0.00372	CcSEcCtD
Calcipotriol—Dermatitis—Bleomycin—skin cancer	0.000287	0.00372	CcSEcCtD
Calcipotriol—Hypersensitivity—Temozolomide—skin cancer	0.000283	0.00367	CcSEcCtD
Calcipotriol—Pruritus—Temozolomide—skin cancer	0.000272	0.00352	CcSEcCtD
Calcipotriol—Rash—Dactinomycin—skin cancer	0.000268	0.00347	CcSEcCtD
Calcipotriol—Hypersensitivity—Fluorouracil—skin cancer	0.000261	0.00338	CcSEcCtD
Calcipotriol—Pruritus—Fluorouracil—skin cancer	0.000251	0.00324	CcSEcCtD
Calcipotriol—Rash—Temozolomide—skin cancer	0.000243	0.00314	CcSEcCtD
Calcipotriol—Dermatitis—Temozolomide—skin cancer	0.000242	0.00313	CcSEcCtD
Calcipotriol—Paraesthesia—Docetaxel—skin cancer	0.00023	0.00297	CcSEcCtD
Calcipotriol—Rash—Fluorouracil—skin cancer	0.000224	0.00289	CcSEcCtD
Calcipotriol—Dermatitis—Fluorouracil—skin cancer	0.000223	0.00289	CcSEcCtD
Calcipotriol—Pain—Docetaxel—skin cancer	0.000219	0.00283	CcSEcCtD
Calcipotriol—Hypersensitivity—Docetaxel—skin cancer	0.000188	0.00244	CcSEcCtD
Calcipotriol—Pruritus—Docetaxel—skin cancer	0.000181	0.00234	CcSEcCtD
Calcipotriol—Rash—Docetaxel—skin cancer	0.000161	0.00209	CcSEcCtD
Calcipotriol—Dermatitis—Docetaxel—skin cancer	0.000161	0.00208	CcSEcCtD
